COVID-19 Impact on Global Next Generation Sequencing Market Size, Status and Forecast 2020-2026
This report focuses on the global Next Generation Sequencing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next Generation Sequencing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Download FREE Sample of this Report @ https://www.24lifesciences.com/report-sample/8867-global-covid-impact-next-generation-sequencing-2020-2026-989
The key players covered in this study
- 454 Life Sciences Corporation (A Roche Company)
- Agilent Technologies
- Biomatters, Ltd
- CLC Bio
- GATC biotech AG
- Macrogen
- BGI (Beijing Genomics Institute)
- Illumina
- Life Technology Corporation
- EMC Corporation
- Dnastar
Market segment by Type, the product can be split into
- Targeted Sequencing & Resequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
- Market segment by Application, split into
- Whole-genome Sequencing
- Exome Sequencing
- Targeted Resequencing
- De Novo Sequencing
- RNA Sequencing
- ChIP Sequencing
- Methyl Sequencing
- Others
Market segment by Regions/Countries, this report covers
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
The study objectives of this report are:
- To analyze global Next Generation Sequencing status, future forecast, growth opportunity, key market and key players.
- To present the Next Generation Sequencing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Next Generation Sequencing are as follows:
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Get the Complete Report & TOC @ https://www.24lifesciences.com/market-reports/global-covid-impact-next-generation-sequencing-2020-2026-989-8867
Table of content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Next Generation Sequencing Revenue
1.4 Market Analysis by Type
1.4.1 Global Next Generation Sequencing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Targeted Sequencing & Resequencing
1.4.3 Whole Genome Sequencing
1.4.4 Whole Exome Sequencing
1.5 Market by Application
1.5.1 Global Next Generation Sequencing Market Share by Application: 2020 VS 2026
1.5.2 Whole-genome Sequencing
1.5.3 Exome Sequencing
1.5.4 Targeted Resequencing
1.5.5 De Novo Sequencing
1.5.6 RNA Sequencing
1.5.7 ChIP Sequencing
1.5.8 Methyl Sequencing
1.5.9 Others
1.6 Coronavirus Disease 2019 (Covid-19): Next Generation Sequencing Industry Impact
1.6.1 How the Covid-19 is Affecting the Next Generation Sequencing Industry
1.6.1.1 Next Generation Sequencing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Next Generation Sequencing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Next Generation Sequencing Players to Combat Covid-19 Impact
1.7 Study Obj
CONTACT US:
North Main Road Koregaon Park, Pune, India - 411001.
International: +1(646)-781-7170
Asia: +91 9169164321
Email: [email protected]